-
Symbol
-
CRSP on Nasdaq
-
Investment type
-
Equity / Common Stock
-
Latest Disclosed Ownership
-
4.97M shares
-
Security Ownership
-
5.5%
ORBIS INVESTMENT MANAGEMENT LTD ownership in CRISPR Therapeutics AG Common Stock (CRSP)
2025-11-14 - ORBIS INVESTMENT MANAGEMENT LTD has filed an SCHEDULE 13G form with the Securities and Exchange Commission (SEC) disclosing ownership of 4.97M shares of CRISPR Therapeutics AG Common Stock (CRSP).
This represents 5.5% percent ownership of the company.